Anthem Blue Cross and Blue Shield Nevada policy
MED.00148 Gene Therapy for Metachromatic Leukodystrophy
MED.00148 Gene Therapy for Metachromatic Leukodystrophy is a public Anthem Blue Cross and Blue Shield Nevada policy (policy MED.00148). It lists 4 CPT or HCPCS codes, 4 of them on the Anthem Blue Cross and Blue Shield Nevada prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- MED.00148
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield Nevada prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross and Blue Shield Nevada policies |
|---|---|---|---|
| 38206 | On the list | Blood-Derived Hematopoietic Progenitor Cell Harvesting, Transplantation/Collection; Autologous | Policies naming 38206 |
| 38232 | On the list | Bone Marrow Harvesting For Transplantation; Autologous | Policies naming 38232 |
| 38241 | On the list | Hematopoietic progenitor cell (HPC); autologous transplantation | Policies naming 38241 |
| J3391 | On the list | Injection, atidarsagene autotemcel, per treatment | Policies naming J3391 |
All Anthem Blue Cross and Blue Shield Nevada policies · Anthem Blue Cross and Blue Shield Nevada prior authorization CPT list